Login / Signup

A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.

Nikolaos SpanakisKaterina KasselaNikolas DovrolisMaria BampaliElisavet GatzidouAthanasia KafasiElisavet FroukalaAnastasia StavropoulouKonstantinos LilakosStavroula VeletzaSotirios TsiodrasAthanasios TsakrisIoannis Karakasiliotis
Published in: Journal of medical virology (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Chains of infections starting from various countries worldwide seeded the outbreak of COVID-19 in Athens, capital city of Greece. A full-genome analysis of isolates from Athens' hospitals and other healthcare providers revealed the variety of SARS-CoV-2 that initiated the pandemic before lockdown and passenger flight restrictions. A dominant variant, encompassing the G614D amino acid substitution, spread through a major virus dispersal event, and sporadic introductions of rare variants characterized the local initiation of the epidemic. Mutations within the genome highlighted the genetic drift of the virus as rare variants emerged. An important variant contained a premature stop codon in orf7a leading to the truncation of a possibly important for viral pathogenesis domain. This study may serve as a reference for resolving future lines of infection in the area, especially after resumption of passenger flight connections to Athens and Greece during summer of 2020.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • healthcare
  • copy number
  • genome wide
  • amino acid
  • gene expression
  • late onset
  • dna methylation
  • single cell
  • current status